New Delhi | Jagran News Desk: The coronavirus vaccine being developed by teams at the University of Oxford will be priced at Rs 500-600, Serum Institute of India's chief executive Officer Adar Poonawalla said on Thursday, adding that the vaccine will be made available to the general public in next three to four months.

Speaking at the Hindustan Times Leadership Summit, Poonawalla said that about 300-400 dozes of the vaccine will be available for the first quarter of 2021. He however, added that the entire population will not be immunised until 2024.

“As many private players will have to be brought in to partner with the government for enhanced distribution of the vaccine… we see more of that happening,” he said. 

Pune-based Serum Institute of India (SII) has partnered with AstraZeneca to produce at one billion doses of coronavirus vaccine. The highly awaited vaccine is branded as Covidshield and the manufactuers and researchers are hopeful that it will be an immunogenic and efficacious vaccine that is going to be useful for mass use. 

Earlier this month, this month, Poonawalla had said India is likely to get as many as 100 million shots of Oxford-AstraZeneca's Covid-19 vaccine by December this year for an inoculation drive across the country that may also start the same month. Poonawalla, according to a Bloomberg report, said that the initial amount of vaccine shots will be produced for India, but distributed on a 50-50 basis between New Delhi and Covax, which is buying the doses for poor nations and has the WHO backing.

India has second highest cases of coronavirus in the world after United States.

Posted By: Lakshay Raja